Innovate or Perish: Managing the Enduring Technology Company in the Global Market (Hardcover)

ABOUT THE EDITOR

ABOUT THE AUTHORS.

PREFACE BY HENRY CHESBROUGH.

Part 1:  PRINCIPLES OF GLOBAL LEADERSHIP IN THE ENDURING TECHNOLOGY COMPANY.

1 THE POLYMATH CEO: ENLIGHTENED LEADERSHIP FOR THE ENDURING TECHNOLOGY COMPANY (EDWARD KAHN).

PART 2: INTELLECTUAL PROPERTY MANAGEMENT.

2 THE IP TOOLKIT: MAXIMIZING BUSINESS VALUE FROM INTELLECTUAL PROPERTY (EDMUND WALSH).

3 HARVESTING NEW INTELLECTUAL ASSETS: THE ROLE OF BUSINESS METHOD PATENTS AND TRADE SECRETS IN STRATEGIC IP MANAGEMENT (KARL JORDA and WAYNE JAESCHKE).

4 GIANTS CAN BE NIMBLE: THE SBC STORY (ABHA DIVINE).

5 INNOVATION ASSET PORTFOLIO: THE INTELLECTUAL PROPERTY MUSE GETS AN MBA (DAMON MATTEO).

PART 3: INNOVATION.

6 INNOVATION STRATEGY: THE ESSENTIAL INGREDIENT (MICHAEL KAYAT).

7 MAXIMIZING INNOVATION TEAMS: THE INTERNAL AND EXTERNAL CONNECTION NETWORK (CARSTEN WITTRUP).

8 ROAD-MAPPING DISRUPTIVE TECHNICAL THREATS AND OPPORTUNITIES IN COMPLEX, TECHNOLOGY-BASED SUBSYSTEMS: THE SAILS METHODOLOGY (BRUCE VOJAK and FRANK CHAMBERS).

PART 4: PARTNERED TECHNOLOGY AND BUSINESS DEVELOPMENT.

9 OPEN FOR BUSINESS: THE AIR PRODUCTS AND CHEMICALS STORY (JOHN TAO and VINCENT MAGNOTTA).

APPENDIX 9A: DETERMINING FAIR ROYALTY RATES FOR UNIVERSITY-DEVELOPED TECHNOLOGY EXCLUSIVE LICENSE OPTION.

10 DEVELOPING GROWTH STRATEGIES USING INTELLECTUAL ASSETS AND STRATEGIC ALLIANCES (DENNIS McCULLOUGH).

11 INNOVATION AND THE BIOPHARMACEUTICAL INDUSTRY: CRISIS OR CROSSROADS? (RONALD LINDSAY).

12 BUILDING COMPANIES ON NOT-SO-FERTILE SOIL (TERI WILLEY).

INDEX.